Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1974 Apr;49(4):283–291. doi: 10.1136/adc.49.4.283

Effect of moderate dosage of chlorpropamide in pregnancy on fetal outcome

H W Sutherland, P D Bewsher, J D Cormack, C R T Hughes, Anne Reid, G Russell, J M Stowers
PMCID: PMC1648755  PMID: 4830117

Abstract

The outcome of 19 pregnancies is reviewed in women receiving daily doses of at least 200 mg chlorpropamide for varying degrees of glucose intolerance. 4 required insulin in late pregnancy. In 13 mothers who had chlorpropamide during the first 13 weeks of pregnancy no fetal abnormality occurred. There were 2 intrauterine deaths, 1 neonatal death, 6 babies with birthweights greater than the 90th centile, and 2 with birthweights below the 10th centile. The total dosage taken during pregnancy varied from 5 to 105 g and the duration of administration varied from 3 to 39 weeks. Though the severity of diabetes loosely correlated with the daily chlorpropamide dosage, no constant relation existed between high daily dosage of chlorpropamide and obstetric or neonatal complications. It is concluded that it is more likely to be the poor control of the maternal diabetes in pregnancy than a pharmacological effect of the chlorpropamide on the fetal pancreas which is responsible for the poor results reported. 6 infants had intravenous glucose tolerance tests done within 3 hours of birth and the rate of glucose disposal and insulin response was found to be greater than in infants of untreated mothers with less severe diabetes.

Full text

PDF
283

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. M., Milner R. D., Strich S. J. Pathological changes in the nervous system in severe neonatal hypoglycaemia. Lancet. 1966 Aug 13;2(7459):372–375. doi: 10.1016/s0140-6736(66)92664-x. [DOI] [PubMed] [Google Scholar]
  2. BROWN R. J., WALLIS P. G. Hypoglycaemia in the newborn infant. Lancet. 1963 Jun 15;1(7294):1278–1282. doi: 10.1016/s0140-6736(63)91981-0. [DOI] [PubMed] [Google Scholar]
  3. Douglas C. P., Richards R. Use of chlorpropamide in the treatment of diabetes in pregnancy. Diabetes. 1967 Jan;16(1):60–61. doi: 10.2337/diab.16.1.60. [DOI] [PubMed] [Google Scholar]
  4. HALES C. N., RANDLE P. J. Immunoassay of insulin with insulin-antibody precipitate. Biochem J. 1963 Jul;88:137–146. doi: 10.1042/bj0880137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. HANDELSMAN M. B., LEVITT L., CALABRETTA M. F. A laboratory and clinical study of chlorpropamide in ambulatory diabetics. Ann N Y Acad Sci. 1959 Mar 30;74(3):632–642. doi: 10.1111/j.1749-6632.1959.tb39589.x. [DOI] [PubMed] [Google Scholar]
  6. HAWORTH J. C., COODIN F. J., FINKEL K. C., WEIDMAN M. L. Hypoglycemia associated with symptoms in the newborn period. Can Med Assoc J. 1963 Jan 5;88:23–28. [PMC free article] [PubMed] [Google Scholar]
  7. HUGGETT A. S., NIXON D. A. Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose. Lancet. 1957 Aug 24;273(6991):368–370. doi: 10.1016/s0140-6736(57)92595-3. [DOI] [PubMed] [Google Scholar]
  8. Kemball M. L., McIver C., Milner R. D., Nourse C. H., Schiff D., Tiernan J. R. Neonatal hypoglycaemia in infants of diabetic mothers given sulphonylurea drugs in pregnancy. Arch Dis Child. 1970 Oct;45(243):696–701. doi: 10.1136/adc.45.243.696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. MALINS J. M., COOKE A. M., PYKE D. A., FITZGERALD M. G. SULPHONYLUREA DRUGS IN PREGNANCY. Br Med J. 1964 Jul 18;2(5402):187–187. doi: 10.1136/bmj.2.5402.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. MOSS J. M., CONNOR E. J. PREGNANCY COMPLICATED BY DIABETES. REPORT OF 102 PREGNANCIES INCLUDING ELEVEN TREATED WITH ORAL HYPOGLYCEMIC DRUGS. Med Ann Dist Columbia. 1965 Jun;34:253–260. [PubMed] [Google Scholar]
  11. NELIGAN G. A., ROBSON E., WATSON J. Hypoglycaemia in the newborn. A sequel of intrauterine malnutrition. Lancet. 1963 Jun 15;1(7294):1282–1284. doi: 10.1016/s0140-6736(63)91982-2. [DOI] [PubMed] [Google Scholar]
  12. Notelovitz M. Sulphonylurea therapy in the treatment of the pregnant diabetic. S Afr Med J. 1971 Feb 27;45(9):226–229. [PubMed] [Google Scholar]
  13. STERNE J., LAVIEUVILLE M. [Clinical research on the effects of oral antidiabetics on the fetus]. Presse Med. 1963 Jun 22;71:1547–1549. [PubMed] [Google Scholar]
  14. Sutherland H. W., Stowers J. M., Cormack J. D., Bewsher P. D. Evaluation of chlorpropamide in chemical diabetes diagnosed during pregnancy. Br Med J. 1973 Jul 7;3(5870):9–13. doi: 10.1136/bmj.3.5870.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Thomson A. M., Billewicz W. Z., Hytten F. E. The assessment of fetal growth. J Obstet Gynaecol Br Commonw. 1968 Sep;75(9):903–916. doi: 10.1111/j.1471-0528.1968.tb01615.x. [DOI] [PubMed] [Google Scholar]
  16. Zucker P., Simon G. Prolonged symptomatic neonatal hypoglycemia associated with maternal chlorpropamide therapy. Pediatrics. 1968 Nov;42(5):824–825. [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES